Table 1.

Demographics and baseline characteristics

Treatment group
Placebo
0.025 mg/kg
0.05 mg/kg
0.1 mg/kg
No. subjects   8   5   5   10  
Mean age, y, ± SD   27.0 ± 5.3   25.2 ± 3.3   25.8 ± 5.3   28.2 ± 4.1  
Mean BMI, kg/m2, ± SD   23.9 ± 1.7   23.2 ± 2.7   25.6 ± 1.5   25.7 ± 1.6  
Mean weight, kg, ± SD   74.8 ± 10.3   72.4 ± 10.2   77.9 ± 5.0   82.4 ± 6.6  
Race, no. (%)     
    White   4 (50)   5 (100)   4 (80)   9 (90)  
    African   2 (25)   0   0   1 (10)  
    Asian   2 (25)   0   1 (20)   0  
Baseline values, mean ± SD     
    Hemoglobin level, g/L   149.0 ± 9.0   153.0 ± 8.0   151.0 ± 6.0   148.0 ± 7.0  
    Ferritin concentration, μg/L   131.1 ± 20.5   132.3 ± 22.4   186.4 ± 112.5   171.3 ± 73.9  
    EPO level, IU/L
 		 12.1 ± 3.5
 		 10.0 ± 2.4
 		 13.0 ± 5.2
 		 9.3 ± 1.8
 
Treatment group
Placebo
0.025 mg/kg
0.05 mg/kg
0.1 mg/kg
No. subjects   8   5   5   10  
Mean age, y, ± SD   27.0 ± 5.3   25.2 ± 3.3   25.8 ± 5.3   28.2 ± 4.1  
Mean BMI, kg/m2, ± SD   23.9 ± 1.7   23.2 ± 2.7   25.6 ± 1.5   25.7 ± 1.6  
Mean weight, kg, ± SD   74.8 ± 10.3   72.4 ± 10.2   77.9 ± 5.0   82.4 ± 6.6  
Race, no. (%)     
    White   4 (50)   5 (100)   4 (80)   9 (90)  
    African   2 (25)   0   0   1 (10)  
    Asian   2 (25)   0   1 (20)   0  
Baseline values, mean ± SD     
    Hemoglobin level, g/L   149.0 ± 9.0   153.0 ± 8.0   151.0 ± 6.0   148.0 ± 7.0  
    Ferritin concentration, μg/L   131.1 ± 20.5   132.3 ± 22.4   186.4 ± 112.5   171.3 ± 73.9  
    EPO level, IU/L
 		 12.1 ± 3.5
 		 10.0 ± 2.4
 		 13.0 ± 5.2
 		 9.3 ± 1.8
 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal